title: Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement.
authors.forename: R
authors.initials: R
authors.lastname: Bullock
authors.forename: P
authors.initials: P
authors.lastname: Passmore
authors.forename: D
authors.initials: D
authors.lastname: Wilkinson
authors.forename: R
authors.initials: R
authors.lastname: Howard
authors.forename: R
authors.initials: R
authors.lastname: Jones
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D002219:Carbamates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018579:Patient Selection; D048448:Phenylcarbamates; D000068836:Rivastigmine
chemical_list: D002219:Carbamates; D018696:Neuroprotective Agents; D048448:Phenylcarbamates; D000068836:Rivastigmine